FDA Inspection 795522 — Department of Defense - Army

Department of Defense - Army — FEI 2977443

The FDA completed an inspection of Department of Defense - Army on August 20, 2012 in Tripler Army Medical Center, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 20, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tripler Army Medical Center, HI (United States)